DMMDA-2
| Clinical data | |
|---|---|
| Other names | 2,3-Dimethoxy-4,5-methylenedioxyamphetamine; 5,6-Dimethoxy-MDA; 3,4-Methylenedioxy-5,6-dimethoxyamphetamine; 5,6-Dimethoxy-3,4-methylenedioxyamphetamine |
| Routes of administration | Oral |
| Drug class | Serotonergic psychedelic; Hallucinogen; Serotonin releasing agent |
| ATC code |
|
| Pharmacokinetic data | |
| Duration of action | Unknown |
| Identifiers | |
| |
| CAS Number |
|
| PubChem CID | |
| ChemSpider | |
| UNII | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C12H17NO4 |
| Molar mass | 239.271 g·mol−1 |
| 3D model (JSmol) | |
| Melting point | 178 to 180 °C (352 to 356 °F) |
| |
| |
| (what is this?) (verify) | |
DMMDA-2, also known as 2,3-dimethoxy-4,5-methylenedioxyamphetamine or as 5,6-dimethoxy-MDA, is a psychedelic drug of the phenethylamine, amphetamine, and MDxx families related to MDA. It is the derivative of MDA with methoxy groups at the 5 and 6 positions and of MMDA and MMDA-2 with an additional methoxy group at either of these positions.